Cost-Effectiveness of Subcutaneous Interferon Beta-1A in a Sub-Population of Multiple Sclerosis Patients (Kurtzke Expanded Disability Status Scale [EDSS]: >3.5-5.0).
Phillips AL, Edwards NC, Locklear JC
Value Health. 2014 Nov; 17(7):A398. PMID: 27200942.Abstract
